143 related articles for article (PubMed ID: 33470551)
1. Glutathione S-transferase gene polymorphic sequence variations: Association with risk and response to Imatinib among Chronic Myeloid Leukemia patients of Kashmir.
Baba SM; Shah ZA; Pandith AA; Geelani SA; Mir MM; Bhat JR; Gul A; Bhat GM
Int J Lab Hematol; 2021 Oct; 43(5):1000-1008. PubMed ID: 33470551
[TBL] [Abstract][Full Text] [Related]
2. Influence of genetic polymorphisms in glutathione-S-transferases gene in response to imatinib among Brazilian patients with chronic myeloid leukemia.
Delmond KA; Delleon H; Goveia RM; Teixeira TM; Abreu DC; Mello-Andrade F; Reis AADS; Silva DME; Barbosa ADP; Tavares RS; Anunciação CE; Silveira-Lacerda E
Mol Biol Rep; 2021 Mar; 48(3):2035-2046. PubMed ID: 33709282
[TBL] [Abstract][Full Text] [Related]
3.
Baba SM; Pandith AA; Shah ZA; Geelani SA; Bhat JR; Gul A; Guru SA; El-Serehy HA; Koul AM; Mansoor S
Front Oncol; 2021; 11():714421. PubMed ID: 34722260
[TBL] [Abstract][Full Text] [Related]
4. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response.
Rostami G; Assad D; Ghadyani F; Hamid M; Karami A; Jalaeikhoo H; Kalahroodi RA
Mol Genet Genomic Med; 2019 Jul; 7(7):e00717. PubMed ID: 31111691
[TBL] [Abstract][Full Text] [Related]
5. Association of GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms with clinical response to imatinib mesylate treatment among Malaysian chronic myeloid leukaemia patients.
Makhtar SM; Husin A; Baba AA; Ankathil R
J Genet; 2017 Sep; 96(4):633-639. PubMed ID: 28947711
[TBL] [Abstract][Full Text] [Related]
6. GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.
Weich N; Ferri C; Moiraghi B; Bengió R; Giere I; Pavlovsky C; Larripa IB; Fundia AF
Cancer Epidemiol; 2016 Oct; 44():16-21. PubMed ID: 27454607
[TBL] [Abstract][Full Text] [Related]
7. Dual glutathione-S-transferase-θ1 and -μ1 gene deletions determine imatinib failure in chronic myeloid leukemia.
Davies A; Giannoudis A; Zhang JE; Austin G; Wang L; Holyoake TL; Müller MC; Foroni L; Kottaridis PD; Pirmohamed M; Clark RE
Clin Pharmacol Ther; 2014 Dec; 96(6):694-703. PubMed ID: 25188725
[TBL] [Abstract][Full Text] [Related]
8. Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.
Jaruskova M; Curik N; Hercog R; Polivkova V; Motlova E; Benes V; Klamova H; Pecherkova P; Belohlavkova P; Vrbacky F; Machova Polakova K
J Exp Clin Cancer Res; 2017 Apr; 36(1):55. PubMed ID: 28420426
[TBL] [Abstract][Full Text] [Related]
9. Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients.
de Lima LT; Bueno CT; Vivona D; Hirata RD; Hirata MH; Hungria VT; Chiattone CS; Zanichelli MA; Chauffaille Mde L; Guerra-Shinohara EM
Hematology; 2015 Apr; 20(3):137-42. PubMed ID: 25056761
[TBL] [Abstract][Full Text] [Related]
10. Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients.
Annuar AA; Ankathil R; Mohd Yunus N; Husin A; Ab Rajab NS; Abdul Aziz AA; Ibrahim MI; Sulong S
Asian Pac J Cancer Prev; 2021 Feb; 22(2):565-571. PubMed ID: 33639675
[TBL] [Abstract][Full Text] [Related]
11. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia.
Harivenkatesh N; Kumar L; Bakhshi S; Sharma A; Kabra M; Velpandian T; Gogia A; Shastri SS; Biswas NR; Gupta YK
Pharmacol Res; 2017 Jun; 120():138-145. PubMed ID: 28330783
[TBL] [Abstract][Full Text] [Related]
12. Impact of ABCB1 Gene Polymorphisms and Smoking on the Susceptibility Risk of Chronic Myeloid Leukemia and Cytogenetic Response.
Mohammadi F; Shafiei M; Assad D; Rostami G; Hamid M; Foroughmand AM
Iran Biomed J; 2021 Jan; 25(1):54-61. PubMed ID: 33129240
[TBL] [Abstract][Full Text] [Related]
13. Association of ABCB1, ABCG2 drug transporter polymorphisms and smoking with disease risk and cytogenetic response to imatinib in chronic myeloid leukemia patients.
Mohammadi F; Rostami G; Hamid M; Shafiei M; Azizi M; Bahmani H
Leuk Res; 2023 Mar; 126():107021. PubMed ID: 36696828
[TBL] [Abstract][Full Text] [Related]
14. Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia.
Sailaja K; Surekha D; Rao DN; Rao DR; Vishnupriya S
Asian Pac J Cancer Prev; 2010; 11(2):461-4. PubMed ID: 20843134
[TBL] [Abstract][Full Text] [Related]
15. Impact of the BCR-ABL1 fusion transcripts on different responses to Imatinib and disease recurrence in Iranian patients with Chronic Myeloid Leukemia.
Rostami G; Hamid M; Jalaeikhoo H
Gene; 2017 Sep; 627():202-206. PubMed ID: 28627443
[TBL] [Abstract][Full Text] [Related]
16. Genetic Polymorphism of GSTP1, GSTM1 and GSTT1 Genes and Susceptibility to Chronic Myeloid Leukaemia.
Idris HM; Elderdery AY; Khalil HB; Mills J
Asian Pac J Cancer Prev; 2020 Feb; 21(2):499-503. PubMed ID: 32102530
[TBL] [Abstract][Full Text] [Related]
17. Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients.
Elghannam DM; Ibrahim L; Ebrahim MA; Azmy E; Hakem H
Hematology; 2014 Apr; 19(3):123-8. PubMed ID: 23683876
[TBL] [Abstract][Full Text] [Related]
18. Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis.
Cargnin S; Ravegnini G; Soverini S; Angelini S; Terrazzino S
Pharmacol Res; 2018 May; 131():244-254. PubMed ID: 29427770
[TBL] [Abstract][Full Text] [Related]
19. Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?
Bedewy AM; El-Maghraby SM
Hematology; 2013 Jul; 18(4):211-6. PubMed ID: 23394475
[TBL] [Abstract][Full Text] [Related]
20. TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.
Weich N; Ferri C; Moiraghi B; Bengió R; Giere I; Pavlovsky C; Larripa I; Fundia A
Blood Cells Mol Dis; 2016 Jul; 59():129-33. PubMed ID: 27282582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
